SavedAdd your journal

Journals / Retina-Vitreus / 2010 / Cilt: 18 - Sayı: 2

Intravitreal bevacizumab in a case of choroidal neovascularization associated with punctate inner choroidopathy

Noktasal iç koroidopati’ye bağlı koroidal neovaskülarizasyon gelişen bir olguda vitre içi bevacizumab tedavisi

Fehmi Cem KÜÇÜKERDÖNMEZ
Yonca AKOVA
Sibel AKSOY
Yüksel SÜLLÜ
Pages
163–166
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We report a case of punctate inner choroidopathy and discuss the results of intravitreal bevacizumab treatment for CNV.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Punctate inner choroidopathy is an idiopathic, inflammatory disorder that is characterized by yellowish white spots at the level of retina pigment epithelium and inner choroid.
📊
Key Findings & Data:Vision loss occurs mainly due to CNV development, and treatment options include systemic steroids, laser photocoagulation, interferon β1α, and submacular surgery.
💡
Conclusion & Impact:We report a case of punctate inner choroidopathy and discuss the results of intravitreal bevacizumab treatment for CNV.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Punctate inner choroidopathy is an idiopathic, inflammatory disorder that is characterized by yellowish white spots at the level of retina pigment epithelium and inner choroid. It is associated with a high incidence of choroidal neovascularization (CNV). Vision loss occurs mainly due to CNV development, and treatment options include systemic steroids, laser photocoagulation, interferon β1α, and submacular surgery. We report a case of punctate inner choroidopathy and discuss the results of intravitreal bevacizumab treatment for CNV.

Özet

Noktasal iç koroidopati; retina pigment epiteli ve iç koroid seviyesinde birden çok sarımsı beyaz noktasal lezyon ile karakterize, seyrinde yüksek oranda koroidal neovaskülarizasyon (KNV) gelişebilen, sebebi bilinmeyen inflamatuar bir hastalıktır. Görme kaybı genellikle gelişen KNV’a bağlı olup, tedavide sistemik steroidler, laser fotokoagülasyon, fotodinamik tedavi, interferon β1α ve submaküler cerrahi uygulanabilmektedir. Bu çalışmamızda, noktasal iç koroidopatiye bağlı KNV gelişen bir olguda vitre içi bevacizumab tedavisinin sonuçları tartışılmıştır.

🔖

Cite This Article

KÜÇÜKERDÖNMEZ, F. C., AKOVA, Y., AKSOY, S., SÜLLÜ, Y. (2010). Intravitreal bevacizumab in a case of choroidal neovascularization associated with punctate inner choroidopathy. Retina-Vitreus, Cilt: 18 - Sayı: 2, 163–166. https://ajindex.com/articles/305165

References (14)

  1. Watzke RC, Packer AJ, Folk JC, et al.: Punctate inner choroidopathy. Am J Ophthalmol. 1984;98:572-584
  2. Brown J Jr, Folk JC, Reddy CV, et al.: Visual prognosis of multifocal choroiditis, punctate inner choroidopathy, and the diffuse subretinal fibrosis syndrome. Ophthalmology. 1996;103:1100-1105
  3. Folk JC, Gehrs KM.: Multifocal choroiditis with panuveitis, diffuse subretinal fibrosis, and punctate inner choroidopathy. In: Schachat AP: Retina The CV Mosby Co. St. Louis. 2001;1709-1720
  4. Levy J, Shneck M, Klemperer I, et al.: Punctate inner choroidopathy: resolution after oral steroid treatment and review of the literature. Can J Ophthalmol. 2005;40:605-608
  5. Brueggeman RM, Noffke AS, Jampol LM.: Resolution of punctate inner choroidopathy lesions with oral prednisone therapy.Arch Ophthalmol. 2002;120:996
  6. Cirino AC, Mathura JR Jr, Jampol LM.: Resolution of activity (choroiditis and choroidal neovascularization) of chronic recurrent punctate inner choroidopathy after treatment with interferon B-1A. Retina. 2006;26:1091-1092
  7. Chatterjee S, Gibson JM.: Photodynamic therapy: a treatment option in choroidal neovascularisation secondary to punctate inner choroidopathy. Br J Ophthalmol. 2003;87:925-927
  8. Lim JI, Flaxel CJ, LaBree L.: Photodynamic therapy for choroidal neovascularisation secondary to inflammatory chorioretinal disease. Ann Acad Med Singapore. 2006;35:198-202
  9. Olsen TW, Capone A Jr, Sternberg P Jr, et al.: Subfoveal choroidal neovascularization in punctate inner choroidopathy. Surgical management and pathologic findings. Ophthalmology. 1996; 103:2061-2069
  10. Akman A, Kadayifçilar S, Aydin P.: Indocyanine green angiographic findings in a case of punctate inner choroidopathy. Eur J Ophthalmol. 1998;8:191-194
  11. Tiffin PA, Maini R, Roxburgh ST, et al.: Indocyanine green angiography in a case of punctate inner choroidopathy. Br J Ophthalmol. 1996;80:90-91
  12. Wachtlin J, Heimann H, Behme T, et al.: Long-term results after photodynamic therapy with verteporfin for choroidal neovascularizations secondary to inflammatory chorioretinal diseases. Graefes Arch Clin Exp Ophthalmol. 2003;241:899-906
  13. Coco RM, de Souza CF, Sanabria MR.: Photodynamic therapy for subfoveal and juxtafoveal choroidal neovascularization associated with punctate inner choroidopathy. Ocul Immunol Inflamm. 2007;15:27-29
  14. Vossmerbaeumer U, Spandau UH, V Baltz S, et al.: Intravitreal bevacizumab for choroidal neovascularisation secondary to punctate inner